Home ›› 06 Dec 2021 ›› Corporate
Evercare Hospital Dhaka, in an unprecedented achievement in Bangladesh, has successfully completed 50th bone marrow transplant (BMT) at the hospital.
The private hospital came up with the announcement at a press briefing on Sunday. It took more than one year to reach the milestone.
Dr Ratnadeep Chaskar, the chief executive officer and managing director of the hospital, said, “We are the first private hospital in the country to bring the advanced equipment required for BMT.
“With a fully equipped leukemia unit, BMT unit and the treatment planning processes, we hope to help more patients who are fighting the painful fear of losing their lives to cancer,” he added.
According to the release, with a dedicated BMT unit and a leukemia unit, Evercare Hospital Dhaka is fully equipped to tackle different kinds of leukemia using autologous and allogeneic BMT with full match and half match.
Furthermore, the hospital has a stem cell processing lab; a cryopreservation facility; outpatient and inpatient procedure facility; an in-house molecular diagnostic facility which provides fast and accurate diagnosis; BMT beds with central oxygen supply, HEPA Filter and a system for reverse osmosis water purification.
It has a molecular lab which uses state-of-the-art technology of Flow Cytometry to diagnose the specific type of cancer, it added.
Services like subtyping, FLAER-based PNH, immune-histochemistry and PET-scan are available to make a quick and correct assessment of the patient’s condition.
Early diagnosis and planning of BMT procedures is crucial to the treatment of leukemia. Therefore, topnotch treatment planning tests like MRD and IHC tests are used to monitor the effectiveness of the treatment, and adapt for necessary changes.
Dr Abu Jafar Mohammed Saleh, coordinator and senior consultant at Hematology and Stem Cell Transplant of Evercare Hospital Dhaka, said BMT is a very risky procedure that comes with a lot of challenges.
Prior to this development in Evercare Hospital, there was limited treatment for leukemia in the country.
Dr Arif Mahmud, deputy director of medical services of the hospital said, “We have the best facilities for BMT treatment in Evercare Hospital Dhaka. Due to this development, patients don’t need to seek BMT treatment abroad anymore. It is much more cost-effective to do it in the country, and our success rates are as good as developed countries.”
The Evercare Group believes access to healthcare is a fundamental right and invests in emerging markets to bring private, quality driven healthcare to meet the needs of local people.
Evercare has responded to a global challenge to ensure well-being at all ages is provided to those living in emerging markets as a pillar to support sustainable economic development. With this the Group is leading the way in transforming the traditional healthcare model through its integrated cross-continents platform, its impact driven model and quality driven hospitals.
The Evercare Group operates as an integrated healthcare delivery platform in emerging markets across Africa and South Asia, including India, Pakistan, Bangladesh, Kenya and Nigeria.
The Group’s portfolio includes 30 hospitals with 3445 beds, 16 clinics, 82 diagnostics centres and two brownfield assets spread over 6 countries. Evercare is proud to be the most diverse healthcare group in the countries it operates in with 11,000 caregivers working together to develop a systemic healthcare change in emerging markets.
Evercare is wholly owned by the Evercare Health Funds, a US $1bn emerging markets healthcare fund managed by The Rise Funds, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world’s leading development finance institutions and other impact investors around the world.
